Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Cell Reports|February 11, 2026
Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signalingMees Botman, Josje M A Huisman, Alexandra Drakaki, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTLAndreas Pilz, Wolfgang Kratky, Silvia Stockinger, et al.Oncotarget|March 9, 2018
Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinomaNataliya Rohr-Udilova, Eva Bauer, Gerald Timelthaler, et al.Blood Cancer Journal|August 19, 2024
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activityJudith Lind, Osman Aksoy, Michaela Prchal-Murphy, et al.Frontiers in Immunology|May 31, 2017
The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell DevelopmentMirte Post, Angelica Cuapio, Markus Osl, et al.European Journal of Immunology|July 1, 2014
Type I interferons have opposing effects during the emergence and recovery phases of colitisIsabella Rauch, Eva Hainzl, Felix Rosebrock, et al.The Journal of Clinical Investigation|December 4, 2004
TYK2 is a key regulator of the surveillance of B lymphoid tumorsDagmar Stoiber, Boris Kovacic, Christian Schuster, et al.Cell Death & Disease|December 12, 2019
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemiaChi Huu Nguyen, Katharina Bauer, Hubert Hackl, et al.Cancer Medicine|December 29, 2017
AKT3 drives adenoid cystic carcinoma development in salivary glandsKatalin Zboray, Julian Mohrherr, Patricia Stiedl, et al.Scientific Reports|June 26, 2019
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressivenessChi Huu Nguyen, Tobias Glüxam, Angela Schlerka, et al.Pageof 7